Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Premier, Inc. Declares Quarterly Cash Dividend: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.19 per share of Class A common stock issued and

Quidel Signs Retail Distribution Agreement to Increase Access to At-Home COVID-19 Testing
Quidel Signs Retail Distribution Agreement to Increase Access to At-Home COVID-19 Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has

Quidel Announces Preliminary Revenue for First Quarter 2021
Quidel Announces Preliminary Revenue for First Quarter 2021


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today preliminary results

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic


Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina’s

Agilent LC/MS Instruments Receive ACT Labels from My Green Lab
Agilent LC/MS Instruments Receive ACT Labels from My Green Lab


Agilent Technologies Inc. (NYSE: A) announced today that both the InfinityLab LC/MSD iQ and the Ultivo Triple Quadrupole LC/MS systems have earned the highly-respected Accountability, Consistency

STAAR Surgical to Report First Quarter Results on May 5, 2021: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report First Quarter Results on May 5, 2021


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

EOS imaging Reports its Full Year 2020 Results and First Quarter 2021 Revenues
EOS imaging Reports its Full Year 2020 Results and First Quarter 2021 Revenues


Regulatory News:



EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year


Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta®, the new

Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Tuesday, May 4, 2021, to discuss its financial and

U.S. FDA Renews Licenses of DILIsym Software: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
U.S. FDA Renews Licenses of DILIsym Software


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS)

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test


Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company

AMN Healthcare CSR Report Shows How AMN Fulfilled Its Social Responsibility in a Year of Unprecedented Challenges
AMN Healthcare CSR Report Shows How AMN Fulfilled Its Social Responsibility in a Year of Unprecedented Challenges


AMN Healthcare (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation, released its 2020 Corporate Social

LivaNova Achieves Clinical Milestone in Heart Failure Program: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Achieves Clinical Milestone in Heart Failure Program


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has randomized the 300th patient in the Autonomic Regulation Therapy to Enhance Myocardial

Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology
Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology


Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin


Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new

Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen
Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen


Eckert & Ziegler erweitert seinen Produktionsstandort in Berlin um eine neue Produktionsanlage für die Auftragsfertigung von Radiopharmazeutika. Die neue GMP-Anlage mit einer Gesamtfläche von rund

Agilent Named One of Singapore’s Best Employers
Agilent Named One of Singapore’s Best Employers


Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a

Hanger Announces Date of 2021 First Quarter Earnings Release and Conference Call
Hanger Announces Date of 2021 First Quarter Earnings Release and Conference Call


Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the first quarter ended March 31

BIOCORP und ROCHE DIABETES CARE FRANCE bringen Mallya auf den Markt – das innovative medizinische Gerät verbessert die Lebensqualität von Diabetes-Patienten: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP und ROCHE DIABETES CARE FRANCE bringen Mallya auf den Markt – das innovative medizinische Gerät verbessert die Lebensqualität von Diabetes-Patienten


Pflichtmitteilung:



BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / PEA/KMU-qualifiziert), ein französisches Unternehmen mit Spezialisierung auf Design, Entwicklung und Herstellung von innovativen

Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization: https://mms.businesswire.com/media/20191105005256/en/560437/5/Waters_logo_K.jpg
Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization


Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based

BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes


Regulatory News:



BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME) , a French company specialized in the design, development and manufacturing of innovative medical devices, and

Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today reported

Community Healthcare System Partners with Premier, Inc. to Drive Operational Innovation and High-Quality Patient Care: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Community Healthcare System Partners with Premier, Inc. to Drive Operational Innovation and High-Quality Patient Care


Community Healthcare System, recognized for high-quality care across Northwest Indiana, has partnered with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company. Through this new

NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of spatial biology abstracts that